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Abstract A tryptophan-rich octapeptide, C8 (Ac-Trp-
Glu-Asp-Trp-Val-Gly-Trp-Ile-NH2), modelled on the
membrane-proximal external region of the feline immuno-
deWciency virus (FIV) gp36 glycoprotein ectodomain,
exhibits potent antiviral activity against FIV. A mechanism
has been proposed by which the peptide, being positioned
on the surface of the cell membrane, inhibits its fusion with
the virus. In the present work, peptide–lipid interactions of
C8 with dimyristoyl phosphatidylcholine liposomes are
investigated using electron spin resonance spectroscopy of
spin-labelled lipids. Three other peptides, obtained from
modiWcations of C8, have also been investigated, in an
attempt to clarify the essential molecular features of the
interactions involving the tryptophan residues. The results
show that C8 adsorbs strongly on the bilayer surface. Mem-
brane binding requires not only the presence of the Trp res-
idues in the sequence, but also their common orientation
on one side of the peptide that is engendered by the
WX2 WX2 W motif. Membrane interaction correlates
closely with peptide antiviral activity, indicating that the
membrane is essential in stabilizing the peptide conforma-
tion that will be able to inhibit viral infection.
Keywords Feline immunodeWciency virus · Membrane · 
Electron spin resonance · Spin-label
Introduction
Both the human immunodeWciency virus (HIV) and the feline
analogue (FIV) eVect cell entry via a mechanism that involves
a surface glycoprotein (Pancino et al. 1995; Serres 2000; Frey
et al.  2001). These glycoproteins, named gp41 and gp36,
respectively, exhibit a common structural architecture consist-
ing of a transmembrane (TM) region and membrane-proximal
segment (pre-TM) that is directly involved in the virus-target
cell fusion. Furthermore, both proteins present an unusual
clustering of tryptophan residues in the membrane-proximal
external region (MPER) of the ectodomain of the TM region
(Giannecchini et al. 2004; Suarez et al. 2000; Salzwedel et al.
1999). The presence of the MPER domain has been shown to
be crucial, through a still unidentiWed mechanism, in the
infection pathway (Barbato et al. 2003).
Peptides deriving from MPER of gp41 and gp36 are able
to prevent HIV- and FIV-cell membrane fusion (Jiang et al.
1993; Jin et al. 2000; Wild et al. 1994; Kilby et al. 2002;
Massi et al. 1998; Giannecchini et al. 2003). The antiviral
activity is likely to derive from adsorption of the peptide on
the external surface of the target-cell membrane, where it
competes with the TM glycoprotein of the virus (Schibli
et al. 2001). In this context, we have recently investigated
the interactions between an antiviral peptide derived from
the MPER domain of the FIV surface glycoprotein and
phospholipid membranes. A 20-mer peptide named P59,
corresponding to the 767L-G786 sequence of (TM) gp36, was
synthesized and found to exert potent inhibitory activity on
FIV replication (Esposito et al. 2006). Subsequently, we
investigated interactions of P59 with phospholipid bilayers
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by electron spin resonance (ESR) experiments, using spin-
labelled lipids (D’Errico et al. 2008). The results demon-
strate that the P59 peptide associates with lipid bilayers by
binding at the membrane surface or polar–apolar interface.
This is consistent with high-resolution nuclear magnetic res-
onance (NMR) analysis of P59 in micellar environments,
which revealed a region of secondary structural order in the
sequence extending from Trp770 to Ile777 (Giannecchini et al.
2007). In particular, an amphipathic, turn-helical structure
forms, in which the polar or charged residues are positioned
on one side, with the opposite side occupied by hydrophobic
residues including the three tryptophans, which have a pro-
pensity to localize to the polar–apolar interface of mem-
branes (White and Wimley 1998; de Planque et al. 1998).
This sequence seems to be fundamental in determining the
peptide antiviral activity. Indeed, an octapeptide with the
770Trp-Ile777 sequence (named C8 or peptide 1; Table 1) was
found to exert an antiviral activity comparable to that of the
P59 20-mer (Giannecchini et al. 2003).
In the present work, we investigate the interaction
between this C8 octapeptide and phospholipid bilayers,
using spin-label ESR and Xuorescence spectroscopy. Sev-
eral analogues of the peptide were also tested, in order to
Wnd which structural features drive the interaction with the
bilayer. Particularly, substitution of the Trp residues or
change of the spacing between them was considered. Our
aim is twofold: on one hand, we wish to test the connection
between antiviral activity of the peptide and its interaction
with the membrane; on the other hand, we wish to investi-
gate more deeply the role played by the MPER domain in
fusion of the virus and target-cell membranes.
Materials and methods
Materials
Dichloromethane and methanol, HPLC-grade solvents,
were obtained from Merck (Darmstadt, Germany). The
phospholipid dimyristoyl phosphatidylcholine (DMPC)
was obtained from Avanti Polar Lipids (Birmingham, AL,
USA). Spin-labelled phosphatidylcholines (n-PCSL) with
the nitroxide group at diVerent positions, n, in the sn-2 acyl
chain were synthesized as described by Marsh and Watts
(1982; Marsh 1997). The spin-labels were stored at ¡20°C
in ethanol solutions at a concentration of 1 mg/ml.
Peptide design and synthesis
Four peptides were designed, synthesized and tested for
membrane interaction. Their amino-acid sequences are
shown in Table 1. Peptide 1, also named C8, corresponds to
the 770Trp-Ile777 sequence of FIV gp36 with three Trp resi-
dues separated by two dipeptide units. The other three pep-
tides have been strategically chosen among a series of C8
mutants whose antiviral activity was tested as reported in a
previous study (D’Ursi et al. 2006). The changes in their
molecular structure allow the analysis of the peptide molec-
ular features driving the peptide/membrane interaction. Par-
ticularly, we have focused our attention on the spacing
between the Trp residues and on their replacements with
other non-natural aromatic residue. In peptide 2, the two
dipeptides have been replaced by a shorter spacer: 3-amino-
propionic acid (or -alanine; Ala), which reduces the dis-
tance along the peptide backbone by two atoms for each
dipeptide replaced by Ala. In order to compensate for the
increased hydrophobicity of peptide 2, an additional Lys
residue has been added at the N-terminus. Lys is the amino
acid occurring naturally at the corresponding position of the
gp36 sequence. In peptide 3, the Trp residues have been
replaced by a non-natural aromatic residue: 3-biphenyl-4-
yl-L-alanine (Bip, see Scheme 1 for the molecular structure).
In peptide 4, the Trp residues have been replaced with a
naphthylalanine isomer: 3-naphthalen-2-yl-L-alanine (Nal2).
Peptides were synthesized manually on a solid phase,
using standard Fmoc/tBu chemistry, as described elsewhere
(D’Ursi et al. 2006). Analytical RP-HPLC indicated
a >97% purity level. The peptides were characterized by
mass spectrometry on a Finningan LCQ-Deca ion trap
instrument equipped with an electrospray source (LCQ
Deca Finnigan, San José, CA, USA); samples were injected
directly in the ESI source using a syringe pump at a Xow
rate of 5 l/min, and spectral data were analysed using
Xcalibur software.
Table 1 Sequence of the peptides and results of FIV inhibition assays
Aromatic residues are highlighted in bold
a Concentration for 50% inhibition of FIV replication, adapted from D’Ursi
et al. 2006
No. Sequence IC50/Ma
1(C8) Ac-Trp-Glu-Asp-Trp-Val-Gly-Trp-Ile-NH2 0.22 § 0.12
2A c - L y s - Trp-Ala-Trp-Ala-Trp-Ile-NH2 >50
3A c - Bip-Glu-Asp-Bip-Val-Gly-Bip-Ile-NH2 >50
4A c - Nal2-Glu-Asp-Nal2-Val-Gly-Nal2-Ile-NH2 0.09 § 0.08
Scheme 1 Structures of non-natural aromatic amino-acid residues.
Bip 3-biphenyl-4-yl-L-alanine, Nal2 3-naphthalen-2-yl-L-alanineEur Biophys J (2009) 38:873–882 875
123
Sample preparation
For ESR experiments, appropriate amounts of DMPC
in dichloromethane/methanol (2/1 v/v) and spin-labelled
phosphatidylcholines in ethanol were mixed in small test
tubes. A thin Wlm of the lipid was produced by evaporat-
ing the solvent with dry nitrogen gas. Final traces of sol-
vent were removed by subjecting the sample to vacuum
desiccation for at least 3 h. The samples were then
hydrated with 20–50 l of 10 mM HEPES, 5 mM EDTA,
150 mM NaCl, pH 7.4 buVer (HBS) and vortexed. The
lipid suspension thus obtained was transferred to a 100-l
glass capillary and pelleted in a tabletop centrifuge. The
supernatant was removed and the capillary was Xame
sealed. Samples containing peptide were prepared in a
similar manner, except that the lipid Wlm was hydrated
directly with the peptide solution in HBS (at a concentra-
tion of 10 mg/ml). In some cases, as discussed below, it
was found that the samples containing peptide 1 (C8)
became optically clear and could no longer be pelleted;
therefore, the sample was used as such for ESR study. In
view of this limitation, the volume of the peptide solution
added was minimized using a higher concentration of the
peptide (20 mg/ml, obtained by gentle warming and soni-
cation), such that the amount of sample in the ESR cavity
was maximized.
ESR spectroscopy
Electron spin resonance spectra of lipid and lipid/peptide
samples were recorded on a 9-GHz Bruker EMX EPR
spectrometer with a model ER 041 XK-D microwave
bridge. Capillaries containing the samples were placed
in a standard 4-mm quartz sample tube containing light
silicone oil for thermal stability. The temperature of the
sample was regulated and maintained constant during the
measurement by blowing thermostated nitrogen gas
through a quartz dewar. The instrumental settings were
as follows: sweep width 120 G, resolution 1,024 points,
modulation frequency 100 kHz, modulation amplitude
1.0 G, time constant 20.5 ms, incident power 5.0 mW.
Several scans, typically 16, were accumulated to improve
the signal-to-noise ratio. Values of the outer hyperWne
splitting, 2Amax, were determined by measuring the diVer-
ence between the low-Weld maximum and the high-Weld
minimum (Marsh and Horváth 1998; Schorn and Marsh
1997). The main source of error on the 2Amax value is the
uncertainty in composition of samples prepared by mixing
few microlitres of mother solutions. For this reason,
reproducibility of 2Amax determination was estimated by
evaluating its value for selected independently prepared
samples with the same nominal composition. It was found
to be § 0.2–0.3 G.
Circular dichroism spectroscopy
Circular dichroism (CD) experiments were performed at
30°C on a 810-Jasco spectropolarimeter using a quartz
cuvette with a path length of 1 mm. CD spectra of peptides
1 and 2 in water were measured in HBS and in the presence
of DMPC unilamellar vesicles. Samples prepared for
CD measurements contained the peptide (1.5 £ 10¡4 M)
and the phospholipid at a tenfold higher concentration
(1.5 £ 10¡3 M). Unilamellar vesicles were obtained from
multilamellar vesicles by sonication for 3–4 h and succes-
sive extrusion through a polycarbonate membrane of 100-
nm pore size. During all the measurements, the trace of the
high tension voltage was checked to be <700 V, which
should ensure reliability of the data obtained (Kelly et al.
2005). Base lines of either solvent or vesicular suspensions
without peptide were subtracted from each respective sam-
ple to yield the peptide contribution.
Fluorescence spectroscopy
In the case of peptide 1 (C8), peptide–liposome interactions
were studied by monitoring the changes in the Trp Xuores-
cence emission spectra in the presence of unilamellar vesi-
cles formed from DMPC. Samples prepared for Xuorescence
measurements contained the peptide (3.5 £ 10¡5 M) and
the phospholipid at a tenfold higher concentration (3.5 £
10¡4 M).
Fluorescence measurements were performed at 30°C
using a Fluorolog-3 spectroXuorimeter (Jobin Yvon). The
excitation wavelength was 280 nm and emission spectra
were recorded between 310 and 450 nm with slit widths of
2n m .
Results
ESR spectra
Association of the four peptides with lipid membranes can
be detected from the perturbation of the chain mobility of
spin-labelled lipids using ESR spectroscopy (Ramakrishnan
et al. 2003; Swamy and Marsh 2001; Sankaram and Marsh
1993). The samples investigated were spin-labelled
phosphatidylcholine (5-PCSL) in DMPC membranes, in the
presence and absence of peptides. As an example, ESR
spectra from DMPC membranes in the presence and
absence of peptide 1 (C8), recorded at temperatures above
and below the chain-melting transition of DMPC (24°C),
are shown in Fig. 1. SigniWcant perturbations due to the
peptide are detectable (compare solid and dashed lines).
A quantitative analysis of this eVect can be done by plotting
the temperature dependences of the outer hyperWne876 Eur Biophys J (2009) 38:873–882
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splittings (2Amax) of 5-PCSL, as shown in Fig. 2. In the
absence of any peptide, a sharp decrease in 2Amax is evident
at the chain-melting temperature, corresponding to the
increase in the spin-label rotational mobility on transition
from the gel to the Xuid phase (Ramakrishnan et al. 2003).
Addition of 0.7:1 wt/wt peptide to DMPC membranes
causes changes in 2Amax, the extent of which depends on
the particular peptide. This peptide/lipid ratio has been cho-
sen because, in the case of interacting peptides, it ensures
the bilayer to be completely perturbed, see the following
subsection. Peptide 1 (C8) causes the largest eVects of the
peptides studied. The chain-melting transition is broadened
almost beyond detection by the interaction with C8: 2Amax
decreases in the gel phase and increases strongly in the Xuid
phase. Peptide 2 shows negligible interaction, hardly
changing the transition and values of 2Amax. Peptide 3 also
produces only small perturbation of 2Amax, i.e. little inter-
action with lipid membranes. In the presence of peptide 4,
the co-operativity of the DMPC chain-melting transition is
strongly reduced, even if its position remains approxi-
mately the same. Above the transition temperature, peptide
4 causes a very signiWcant increase in 2Amax, although less
than that observed for peptide 1.
As a comparison, data for the 20-mer peptide P59,
whose sequence includes that of C8, are also shown in
Fig. 2 (D’Errico et al. 2008). It is clear that C8 perturbs the
mobility of the membrane to an equal, or even greater,
extent than does the longer, parent P59 peptide.
Peptide–lipid titration
Because peptides 1 and 4 showed appreciable eVects on
lipid mobility, we investigated their interaction with DMPC
bilayers further. Figure 3 shows the increase in outer hyper-
Wne splitting, 2Amax, of 5-PCSL in DMPC membranes
with increasing peptide concentration. With both peptides,
a typical saturation trend is registered (Ramakrishnan et al.
2003): the decrease in lipid chain mobility saturates with a
value of 2Amax t 3.3 G for peptide 1 and 2Amax t 1.7 G
for peptide 4. The stoichiometry of the interaction can be
estimated by extrapolation of the increase in 2Amax, on
initial tight binding, to the saturation value of 2Amax.
In both cases, this yields a stoichiometry of one peptide
molecule bound per six lipids. On a per-residue basis (0.75
lipids), this is the same stoichiometry as obtained for the
20-mer P59 peptide (D’Errico et al. 2008).
It should be noted that the addition of peptide 1 to multi-
lamellar dispersions of DMPC solubilizes the bilayer struc-
tures, so that systems with a peptide to lipid ratio higher
than 0.8 wt/wt appear transparent, a phenomenon already
observed for the P59 peptide (D’Errico et al. 2008).
However, the ESR spectra of the spin-labelled lipid are
Fig. 1 Electron spin resonance spectra of 5-PCSL in dimyristoyl
phosphatidylcholine bilayer membranes, in the presence (solid line)
and in the absence (dashed line) of 0.7:1 wt/wt peptide 1 (C8). The
total scan range is 100 G
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Fig. 2 Temperature dependence of the outer hyperWne splitting,
2Amax, of 5-PCSL in DMPC membranes in the absence (bold line) and
in the presence of 0.7:1 wt/wt peptide: peptide 1 (solid circles), peptide
2 (solid squares), peptide 3 (open circles), peptide 4 (open squares).
For comparison, the temperature dependence in the case of peptide P59
is given by the thin line (adapted from D’Errico et al. 2008)
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insensitive to this change, showing that the lipid chains
continue to be substantially restricted in their motion. No
evidence of liposome solubilization was found for the other
peptides investigated in this work.
Lipid chain Xexibility proWles
Perturbation of the ESR spectra of lipids spin-labelled at
diVerent positions, n, in the sn-2 chain that is induced by
binding peptide 1 or peptide 4 was also investigated.
Figure 4 gives the ESR spectra of the n-PCSL phosphati-
dylcholine spin-label positional isomers in Xuid DMPC
bilayer membranes (T = 30°C), in the presence and absence
of peptide 1 at a peptide to lipid ratio of 0.7:1 wt/wt. In the
absence of peptide, the outer hyperWne splitting decreases
progressively with increasing n, as the spin-label position is
stepped down the chain towards the centre of the mem-
brane. This Xexibility gradient in segmental chain mobility
is a characteristic hallmark of the liquid-crystalline state of
Xuid phospholipid bilayers (Ramakrishnan et al. 2003).
In the presence of bound peptides 1 or 4, the outer hyper-
Wne splitting is increased at all spin-label chain positions.
Figure 5 shows the dependence of the outer hyperWne split-
ting, 2Amax, on chain position, n, for the n-PCSL spin labels
in Xuid DMPC membranes, with and without a saturating
amount of peptide. For both peptides, the characteristic
Xexibility gradient with chain position of the Xuid lipid
Fig. 3 Dependence of the increase, 2Amax, in outer hyperWne split-
ting of 5-PCSL at 30°C on peptide/DMPC ratio for peptide 1 (solid
circles) and peptide 4 (open squares). Data for 20-mer peptide P59
(continuous line) is also shown, adapted from D’Errico et al. 2008.
Dashed lines refer to the procedure used to evaluate the stoichiometry
of the peptide–lipid interaction, see text
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Fig. 4 Electron spin resonance spectra of n-PCSL positional isomers
of spin-labelled phosphatidylcholine in Xuid-phase dimyristoyl phos-
phatidylcholine bilayer membranes, in the presence (solid line) and in
the absence (dashed line) of 0.7:1 wt/wt peptide 1 (C8) at 30°C
5-PCSL 
7-PCSL 
10-PCSL 
14-PCSL 
Fig. 5 Dependence on spin-label position, n, of the outer hyperWne
splitting, 2Amax (left-hand ordinate), of n-PCSL in Xuid-phase mem-
branes of DMPC, in the absence (bold line) and in the presence of
0.7:1 wt/wt peptide 1 (solid circles) or peptide 4 (open squares).
T = 30°C. Right-hand ordinate: increase in outer hyperWne splitting,
2Amax, on adding peptide 1 (solid circles) or peptide 4 (open squares).
Corresponding data for peptide P59, adapted from D’Errico et al. 2008,
are also shown (thin lines)
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bilayer membranes is preserved. In the presence of bound
peptides 1 or 4, the outer hyperWne splitting is increased
at all spin-label chain positions. This indicates that the
increase in lipid packing density, which is induced by sur-
face association of the peptide (Ramakrishnan et al. 2003;
Swamy and Marsh 2001), propagates throughout the chain
region. For either peptide, there is no appearance of a sec-
ond, more motionally restricted component in the spectra of
the spin labels positioned towards the terminal methyl ends
of the chains. This is evidence that the peptides bind solely
at the membrane surface and do not penetrate appreciably
into the membrane interior, as does, for instance, the mye-
lin basic protein or apocytochrome c (Sankaram and Marsh
1993). A similar behaviour was observed in the case of the
P59 peptide (D’Errico et al. 2008).
To verify the eVect of the peptide/lipid ratio on the per-
turbations of the lipid chain Xexibility proWle, a set of mea-
surements was also performed at a lower C8/DMPC weight
ratio (0.12:1 wt/wt). The results, not shown, are qualita-
tively similar to those discussed above, but the changes in
2Amax are almost one-half those reported in Fig. 5 at all
spin-label chain positions.
Circular dichroism spectra
An investigation on the conformational preferences of pep-
tides 1 and 2 in HBS and in the presence of DMPC lipo-
somes was performed by means of CD spectroscopy. Both
peptides in buVer present a spectrum with the typical shape
of a random coil structure, including a negative band at
202 nm. The presence of DMPC liposomes does not signiW-
cantly aVect the CD spectrum of peptide 2. In contrast, the
spectrum of peptide 1 assumes the double-well shape typi-
cal of a turn-helical structure, including negative bands at
205 and 217 nm (Fig. 6).
Fluorescence spectra
The  Xuorescence intensities of some Wne vibronic struc-
tures in the tryptophan Xuorescence spectrum show strong
environmental dependence (Konev 1967; Ambrosone et al.
1997). In particular, the emission maximum shifts from 354
to 329 nm when going from water to an apolar medium.
The quantum yield can also undergo large changes, the
direction and extent of which depend on the system under
consideration (Callis and Liu 2004). Consequently, Xuores-
cence experiments allow evaluation of the polarity experi-
enced by the tryptophans of peptide 1 in DMPC liposomes.
C8 in water (Fig. 7) gives a Trp emission spectrum typi-
cal of an aqueous environment (max t 352 nm), indicating
that the Trp side chains are exposed to the aqueous
medium. The presence of DMPC liposomes causes a weak
shift of the emission maximum to shorter wavelength
(max = 347 nm) and a reduction of the Xuorescence quan-
tum yield. These results are similar to those observed for
P59 (D’Errico et al. 2008) and indicate that, despite the evi-
dent interaction between C8 and DMPC liposomes, the Trp
residues of this peptide are not signiWcantly inserted the
apolar inner core of the bilayer.
Discussion
The C8 octapeptide, derived from the MPER of the FIV
envelope glycoprotein gp36 has been found to exert potent
antiviral activity (Giannecchini et al. 2003; D’Ursi et al.
2006 and see Table 1), a remarkable feature for an oligo-
peptide of such small size. It has been hypothesized that the
Fig. 6 Circular dichroism spectra (range 190–260 nm) of peptide 1 in
aqueous phosphate buVer (dashed line) and in DMPC unilamellar
liposomes (solid line)
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Fig. 7 Tryptophan emission spectra (range 310–450 nm) of peptide 1
in aqueous phosphate buVer (dashed line) and in DMPC unilamellar
liposomes (solid line)
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inhibitory action is due to adsorption of the peptide on the
plasma membrane of the target cell, where it can inhibit
interaction with the virus fusion glycoprotein. To check this
hypothesis, we studied the interactions of C8 and analogues
with lipid membranes using ESR spectroscopy (Marsh and
Watts 1982). When combined with site-speciWcally spin-
labelled lipids, this technique has proved to be a powerful
tool to monitor peptide–membrane interactions. However,
it is not suitable to discriminate the diVerent kinetic steps in
the interaction process (Shai 1999), so that in the following
discussion we shall assume a simple two-state model, in
which only interacting and non-interacting peptides are dis-
tinguished.
Phospholipid bilayers are a simple model system which
allows a detailed analysis of the molecular features inXu-
encing the peptide–membrane interaction. The presence of
two acidic residues in the peptide sequence led us to
choose liposomes formed by the ubiquitous zwitterionic
phospholipid phosphatidylcholine rather than by anionic
lipids. Indeed, in previous work, we found that the electro-
static contribution to the interaction between the 20-mer
peptide P59, whose sequence includes C8, and phospho-
lipid bilayers is negligible (D’Errico et al. 2008). In order
to allow a straightforward interpretation of the data and a
direct comparison with the results already reported for
P59, we also chose not to include other lipids in the bilayer
composition. Indeed, the presence of cholesterol and
sphingomyelin is reported to enhance the interaction
between membranes and peptides derived from the MPER
domain of HIV (Sáez-Cirión et al. 2002; Veiga and
Castanho 2007).
Inspection of the sequence of C8 shows that it is mainly
characterized by the presence of three equally distant
tryptophans in a WX2WX2W motif (Table 1). The presence
of these tryptophan residues and their spatial arrangement
has been found to be essential for the antiviral activity
(D’Ursi et al. 2006). In particular, the substitution of the
indole ring of tryptophan, and/or a change of the ring orien-
tation, led to a dramatic decrease of the peptide activity.
Since tryptophan residues are usually strongly involved in
the interaction with biological membranes, it is possible
that the variation in the peptide antiviral activity is due to
their diVerent ability to interact with the membranes. In
order to investigate this aspect, we also studied the behav-
iour of three analogues, each of them diVering from C8 for
a single molecular feature. Peptide 2 has a shorter spacing
between the Trp residues. In peptides 3 and 4 the Trp resi-
dues have been replaced by a non-natural aromatic amino
acid, Bip or Nal2, with diVerent side chain topology
(Scheme 1). SpeciWcally, Bip is characterized by a non-pla-
nar relative orientation of the two phenyl rings, while Nal2
contains a planar naphthyl group, very similar to the native
indole group of Trp.
The ESR results show that C8 perturbs the lipid chain
motion of DMPC membranes. Particularly, it increases the
chain mobility in the gel phase and reduces it in the Xuid
phase so that the chain-melting transition becomes almost
undetectable. Peptide 4 produces a similar, although
weaker eVect, whereas peptides 2 and 3 do not aVect the
lipid chain-melting transition, indicating that they do not
interact with the membrane. For peptides 1 and 4, the per-
turbation of lipid motion extends along the whole lipid
chain. However, the lack of any speciWc motionally
restricted spin-labelled lipid component in the spectra from
14-PCSL suggests this perturbation to be an indirect eVect
from interfacial association rather than penetration of the
peptide into the membrane.
Taken together, the experimental evidence indicates that
the tryptophan residues play a major role in driving the
interaction between C8 and lipid membranes. The presence
of two conjugated aromatic rings seems important because,
whereas an attenuated interaction is preserved if the indole
group is replaced by a naphthyl one, the interaction is lost
completely if a biphenyl group is substituted. However,
simply the presence of three Trp residues (as in peptide 2)
is insuYcient; they must be spaced such that they are
located on the same side of the putative helix. Conforma-
tional studies by CD and NMR show that all four peptides,
which adopt a prevalent random coil conformation in water,
assume a turn-folded conformation in DMSO/water mix-
tures (Giannecchini et al. 2003; D’Ursi et al. 2006). In the
case of C8 an amphiphilic helix forms, in which the polar
or charged residues are positioned on one side, the opposite
being occupied by hydrophobic residues and by the three
Trp residues, which are known to have a propensity to
locate to the polar–apolar interface. A comparative confor-
mational analysis shows that while the structures of pep-
tides 1 and 4 are almost superimposable, i.e. the Trp and
Nal2 side chains are iso-sterically oriented, this is not true
for peptide 2, because the shorter spacer induces a back-
bone arrangement that minimizes interactions between the
Trp rings, resulting in oppositely oriented side chains.
Our CD data show that C8 assumes a turn-folded confor-
mation in the presence of liposomes, while peptide 2 still
retains a random coil conformation. Thus, the ability of C8
to assume a helical conformation with the Trp residues
exposed on the same side of the helix promotes its interac-
tion with bilayers, which, in turn, stabilizes the peptide con-
formation. In contrast, because the Trp residues are on
diVerent sides of peptide 2 in the helical conformation, this
peptide is not able to interact with the membrane, prefer-
ring to remain in aqueous solution in the random coil con-
Wguration.
Table 1 includes results from FIV inhibition assays,
expressed as 50% inhibitory peptide concentrations, IC50
(highest antiviral activity corresponds to lowest IC50).880 Eur Biophys J (2009) 38:873–882
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There is a strong correlation between inhibitory potency
and membrane interaction of the four peptides. Peptides 1
and 4 have signiWcant and comparable antiviral activities,
which is completely absent for the non-binding peptides 2
and 3. This correlation supports the proposal that the antivi-
ral activity is exerted through a mechanism of peptide
adsorption onto the membrane of the target cell. Adsorbed
peptide protects the cell from the fusion glycoprotein of the
virus. The role played by the membrane in this process is
fundamental in stabilizing the peptide conformation. In
turn, once the peptide has assumed the correct conforma-
tion, it can exert antiviral activity by interacting with the
glycoproteins present on the surface of the approaching
viruses (Lorizate et al. 2008).
Mutagenesis studies and crystal structure determinations
identify a cavity in the TM glycoprotein of immunodeW-
ciency viruses, to which peptide inhibitors could bind. Par-
ticularly, in the case of HIV gp41, the ectodomain core is a
trimer of helical hairpins in which three C helices pack
against a central coiled coil. Each C helix is preferentially
in contact with one of three symmetry-related hydrophobic
cavities on the surface of the coiled coil. In principle, com-
pounds that are able to insert stably in these cavities should
actively block the protein function, thus inhibiting viral
infection. However, small peptides designed to bind in such
a cavity exhibit no antiviral activity, and this has been
attributed to conformational instability (Chan et al. 1998;
Eckert et al. 1999). Indeed, satisfactory antiviral activity
has been shown only by peptides composed of 30 or more
residues (Jin et al. 2000; Yu et al. 2008).
Our data indicate that the unusually high antiviral activ-
ity shown by a short peptide such as C8 is strictly related to
its ability to interact with membranes. Thus, it is likely that
C8 or other derived peptides are able to exert antiviral
activity only if bound to the target cell membrane, which
stabilizes its conformation enabling it to interact with the
gp36 protein of the approaching FIV.
Our results might also give some indication of the role
played by the Trp-rich MPER domain of the viral glycopro-
tein in the process of fusion between FIV and the target-cell
membrane. This is an energy-costing event that involves
destabilization of the bilayer and dehydration of the interfa-
cial regions. Our results show that C8 (and also P59) desta-
bilizes phospholipid bilayer membranes, producing smaller
micelle-like aggregates at peptide to lipid weight ratios >
0.8. This eVect is due to the synergistic action of the three
tryptophan residues. In fact, a similar behaviour has been
recently reported for Trp-Trp and Trp-Trp-Trp oligomers
(Stano et al. 2005). This suggests the existence of a speciWc
interaction between membranes formed by phosphatidyl-
choline lipids and Trp-rich peptides. However, the mecha-
nism and microstructural details of this interaction are not
satisfactorily understood. Our spin-label results exclude a
deep insertion of the peptide in the bilayer, rather indicating
adsorption of the peptide at the membrane interface. This is
further supported by Xuorescence measurements, showing
that, even in the presence of excess DMPC, the tryptophan
residues of C8 are not embedded in the hydrophobic bilayer
inner core, continuing to be located in a polar environment,
such as that deWned by the fully hydrated lipid headgroups.
These results are in agreement with those in the literature.
In fact, Yau et al. (1998) showed that the Trp residues of
peptides interacting with biomembranes tend to be positioned
at the interface. This is related to the aromatic nature of
indole (comprehensive of dipole and quadrupole, H-bond-
ing, cation- and steric interactions), which confer an
amphipathic behaviour on the Trp residue, so that contact
with water is disfavoured and, at the same time, deep pene-
tration into the bilayer hydrophobic core is also precluded.
Molecular dynamic calculations have also shown that
indoles are preferably positioned in the region deWned by
the headgroups and upper acyl chain sections of phosphati-
dylcholine lipids (GrossWeld and Woolf 2002), and linear
dichroism measurements have indicated that the indole
plane is at an oblique angle with respect to the membrane
normal (Esbjörner et al. 2007).
Thus, a possible mechanism through which C8 can
destabilize the bilayer is its intercalation between the
lipid headgroups. This disrupts the hydration structure of
phosphocholine groups (GrossWeld and Woolf 2002) and,
also because of steric reasons, increases the distance
between them. Consequently, the result of the peptide
solubilization is an altered lipid packing, so that the
bilayer evolves towards smaller aggregates with higher
surface curvature. This perturbation is more eVective
because of the Trp residues closeness. It is likely that,
similar to what is observed by small-angle neutron scat-
tering measurements with P59 (D’Errico et al. 2008),
phospholipid liposomes are converted by binding of C8
into smaller rod-like micelles. This destabilizing eVect is
not observed for the other peptides used here, because of
their diminished or non-existent capacity to interact with
the bilayer. Consequently, this eVect also should be
ascribed to the presence of the Trp residues in their
correct orientation.
The destabilizing eVect exerted by the MPER domain,
and speciWcally by the Trp cluster, on the membrane could
be fundamental to the fusion process (Garg et al. 2004).
Indeed, the presence of the MPER domain has been shown
to be crucial in the infection pathway (Barbato et al. 2003).
In the surface glycoproteins of various viruses, including
not only FIV and HIV, but also that responsible for the
severe acute respiratory syndrome (Guillén et al. 2007) and
Ebola infection (Sáez-Cirión et al. 2003), this Trp-rich
domain is located very close to the viral membrane, but
deWnitely protruding from it. Once the fusion peptide hasEur Biophys J (2009) 38:873–882 881
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entered the target-cell membrane and subsequent confor-
mational changes in the glycoprotein have brought the two
membranes into close proximity, the MPER domain could
then destabilize the bilayer of the target cell, thus promot-
ing membrane fusion.
Open Access This article is distributed under the terms of the Cre-
ative Commons Attribution Noncommercial License which permits
any noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
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